Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01346774 · ClinicalTrials.gov registry record · Phase 2
Preventing Urinary Tract Infection Post-Surgery
A Phase 2 study of Urinary Tract Infection, sponsored by Betsy Foxman.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT01346774 is a Phase 2 study of Urinary Tract Infection that has completed, run by Betsy Foxman. The registered enrollment target is 200 participants, below the 655-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01346774, a Phase 2 study of Urinary Tract Infection, has completed, sponsored by Betsy Foxman.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately 10-27% of patients undergoing gynecologic surgeries develop a catheter associated urinary tract infection (CAUTI) in the post operatory period, as bladder catheterization is a common practice in gynecologic surgery. Cranberry products provide alternative means for preventing CAUTI and could result in decreased use of antimicrobials. In this pilot study we will enroll 200 women post gynecologic surgery and randomize them to take either cranberry powder capsules or placebo powder capsules. The low risk of harm associated with using cranberry to reduce UTI coupled with its potential benefit makes it a desirable intervention for the prevention of CAUTI. The conduct/ results of this pilot /feasibility study will prepare us for the conduct of a large scale clinical trial.
Conditions Studied
Interventions
- DRUG Cranberry powder capsules
- DRUG Placebo powder capsules
Study Locations (1)
Michigan
- Urogynecology Clinic; University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01346774
The ClinicalTrials.gov registry entry for NCT01346774 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 655-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (69% lower). The listed sponsor is Betsy Foxman, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Cranberry powder capsules is the first listed.
NCT01346774 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01346774 about?
NCT01346774 is a clinical study titled "Preventing Urinary Tract Infection Post-Surgery". Approximately 10-27% of patients undergoing gynecologic surgeries develop a catheter associated urinary tract infection (CAUTI) in the post operatory period, as bladder catheterization is a common practice in gynecologic surgery. Cranberry products provide alternative means for preventing CAUTI and ...
What is the current status of trial NCT01346774?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2011-06. Estimated completion is 2013-10.
What conditions does trial NCT01346774 study?
This clinical trial studies the following conditions: Urinary Tract Infection.
What interventions are being tested in trial NCT01346774?
The interventions under investigation include: Cranberry powder capsules (DRUG), Placebo powder capsules (DRUG).
Who is sponsoring clinical trial NCT01346774?
This trial is sponsored by Betsy Foxman, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01346774 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures
COMPLETED · Phase 2
-
Short Course Nitrofurantoin for Acute Cystitis
COMPLETED · Phase 2
-
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
RECRUITING · NA
-
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
RECRUITING · NA
-
Cefpodoxime vs Ciprofloxacin for Acute Cystitis
COMPLETED · NA
-
ParentLink: Better and Safer Emergency Care for Children
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.